M. Hinder, A. Frick, P. Jordaan
Dec 1, 2006
Citations
2
Influential Citations
26
Citations
Quality indicators
Journal
Clinical Pharmacology & Therapeutics
Abstract
New anticoagulants that combine effective anticoagulation with low bleeding rates are still sought after. We investigated the safety, pharmacokinetics, and pharmacodynamics of otamixaban, a direct factor Xa inhibitor, in patients with stable coronary artery disease.